Search Results
Nov 18, 2025, 07:30 ET Akadeum Life Sciences Announces Drug Master File Submission to the US FDA for GMP Microbubble Cell Separation
www.akadeum.com. Akadeum Life Sciences Contact: Brandon McNaughton, PhD Chief Executive Officer [email protected]
More news about: Akadeum Life Sciences
Nov 18, 2025, 07:19 ET Monteloeder Botanical Nutricosmetic Clinically Supports Younger Looking Skin
supplementation with Eternalyoung® is associated with notable and clinically observed improvements in the key aspects of skin aging," reports Nuria Caturla, PhD, Chief R&D Officer for Monteloeder. "We witnessed its ability to help improve the appearance of smoother skin, more even tone, enhanced radiance
More news about: Monteloeder, S.L.
Nov 18, 2025, 07:00 ET Vast Therapeutics Completes First Milestone in Phase 1 Clinical Program
Drug Administration. "Vast's targeted approach can be transformational," says James Chalmers, MBChB, PhD, Professor and Consultant Respiratory Physician at the School of Medicine, University of Dundee, UK. "The ability to deliver nitric oxide in
More news about: Vast Therapeutics, Inc.
Nov 18, 2025, 07:00 ET Vincere Biosciences Awarded $5 Million from The Michael J. Fox Foundation to Advance Parkinson's Therapeutic Toward Clinical Trials
our mission to accelerate the development of transformative treatments and, ultimately, a cure for Parkinson's disease," said Jessica Tome Garcia, PhD, MJFF's lead scientific program manager. "Our collaboration with Vincere Biosciences over the years has supported the advancement of research targeting
More news about: Vincere Biosciences
Nov 18, 2025, 07:00 ET Armata Pharmaceuticals Announces Key Opinion Leader Webinar on S. aureus Bacteremia and AP-SA02 Hosted by Jones Research on November 25th at 10:00am EST
The webinar, which is hosted by Jones Research and Senior Research Analyst, Debanjana Chatterjee, PhD, will feature prominent infectious disease specialist Dr. Vance G. Fowler, Jr., MD, from Duke University School of Medicine. Dr. Fowler will discuss
More news about: Armata Pharmaceuticals, Inc.
Nov 18, 2025, 06:48 ET Home for the Holidays: Experts Share Tips for Communicating and Connecting When a Loved One Has Dementia
Bernadette Mayfield-Clarke, PhD, CCC-SLP. "By modifying how you approach a loved one who is dealing with the disease, family and friends can communicate more effectively and have more
More news about: American Speech-Language-Hearing Association (ASHA)
Nov 18, 2025, 06:30 ET Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio
to target complex biology with greater precision and accelerate the development of better therapies." Alfredo Quijano Rubio, PhD, CSO of Monod Bio commented, "NovoBody™ Duo molecules are compact, tunable, and rapidly adaptable for multi-specific binding applications. Unlike traditional
More news about: Bio-Techne Corporation
Nov 17, 2025, 17:42 ET Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London
[email protected] Investor Relations Contact:Aman Patel, CFA & Adanna G. Alexander, PhDICR Healthcare [email protected]
More news about: Cytosorbents Corp
Nov 17, 2025, 15:05 ET RIFM welcomes new Chair and Board members for 2026
research. "On behalf of RIFM, I am delighted to welcome our new Chair, officers, and Board members," said Anne Marie Api, PhD, Fellow ATS, President of RIFM. "Their expertise, experience, and dedication to fragrance safety will be invaluable as we continue to advance our
More news about: Research Institute for Fragrance Materials
Nov 17, 2025, 13:01 ET American Energy + AI Effort to Provide Near-Term Path to Power AI Growth
steel in the ground, projects underway, and a clear research-backed roadmap that industry and policymakers can use," said Ann Bluntzer Pullin, PhD, executive director of the Hamm Institute for American Energy. As the non-political partner, the Hamm Institute is leading the
More news about: CGCN Group
Nov 17, 2025, 13:01 ET Cincinnati Children's accelerating breakthroughs in care for cancer, blood diseases and genetic disorders with new center
for our Applied Gene and Cell Therapy Center will improve outcomes for even more kids with the hardest-to-treat illnesses," said Stella Davies, MBBS, PhD, co-executive director of the health system's Cancer and Blood Diseases Institute as well as director of the Division of Bone Marrow Transplantation
More news about: Cincinnati Children's Hospital Medical Center
Nov 17, 2025, 13:00 ET Prestigious Cabernet Producer Quilceda Creek Raises $335,000 for Cancer Research Institute Through Library Wine Release
to excellence—in winemaking and in giving—mirrors the passion and precision that drive cancer immunotherapy research forward," says Alicia Zhou, PhD, CEO of CRI. "This remarkable gift will help fuel discoveries that bring new hope to patients everywhere." This donation
More news about: Quilceda Creek
Nov 17, 2025, 11:01 ET Lowering Arsenic Levels in Groundwater Decreases Death Rates from Chronic Disease
Besides Chen and Wu, Mengling Liu, PhD, is a study co-investigator from NYU Langone. Also involved in the study are co-lead investigator Alexander van Geen, PhD, and co-investigators Joseph Graziano, PhD, Vesna Slakovich, MS, Tyler Ellis, MS, and Ana Navas-Acien, PhD, at Columbia University in New York
More news about: NYU Langone Health System
Nov 17, 2025, 10:27 ET PRV111, in Development as the First Non-Surgical Therapy for Early-Stage Non-Invasive Oral Cancer and High-Grade Dysplasias, Meets Its Primary Efficacy Endpoint in Ongoing Phase 2/3 Trial
PRV111 delivered a 92% pathologic CR rate, eliminated the need for surgery in all patients, and demonstrated durable local control. Manijeh Goldberg, PhD, MBA, Founder and CEO of Privo Technologies, commented:"The complete response rate achieved with PRV111 is among the highest reported for
More news about: Privo Technologies
Nov 17, 2025, 09:00 ET New Research to Assess Effectiveness of Pet Rental Deposit Assistance Program
supporting pet retention. This grant, awarded to the Institute for Human-Animal Connection at the University of Denver, will be led by Kevin Morris, PhD, Research Professor at the Graduate School of Social Work and Executive Director, Institute for Human-Animal Connection.
More news about: Human Animal Bond Research Institute (HABRI)
Nov 17, 2025, 08:05 ET New long-term data reinforces TREMFYA® (guselkumab) as the only IL-23 inhibitor proven to substantially inhibit structural joint damage in active psoriatic arthritis
inhibit structural damage in active psoriatic arthritis, which can develop in up to 30% of people living with psoriasis," said Leonard Dragone, MD, PhD, Vice President, Rheumatology and Autoantibody Disease Area Leader, Johnson & Johnson Innovative Medicine. "It's durable efficacy and established
More news about: Johnson & Johnson
Nov 17, 2025, 08:04 ET SK Life Science, Inc. Announces Publication of C035 Study Analyses in Epilepsia and Seizure
"These publications represent important progress in our understanding of cenobamate's clinical profile," said Sunita N. Misra, MD, PhD, Senior Vice President, Clinical Development and Medical Affairs, SK Life Science, Inc. "The findings from this study provide additional information
More news about: SK Life Science, Inc.
Nov 17, 2025, 08:00 ET Pioneering Neurologist and Advocate for Holistic Parkinson's Care, Bastiaan Bloem, MD, PhD, Receives the Robert A. Pritzker Prize
2025 Robert A. Pritzker Prize for Leadership in Parkinson's Research to Bastiaan (Bas) Bloem, MD, PhD, a professor of movement disorder neurology and director of the Center of Expertise for Parkinson's Disease at Radboud University Medical Center in Nijmegen,
More news about: The Michael J. Fox Foundation for Parkinson's Research
Nov 17, 2025, 07:00 ET NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute
developing cell-based and small-molecule therapies for neurodegenerative and metabolic diseases, today announced the appointment of Prof. Jeremy Shefner, MD, PhD, to the Company's Scientific Advisory Board ("SAB").
More news about: NewcelX Ltd.
Nov 17, 2025, 07:00 ET Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study
who made this groundbreaking study possible, most importantly the families and investigators for their participation in the trial," said Nikole Kimes, PhD, Co-Founder and Chief Executive Officer of Siolta Therapeutics. "By targeting the microbiome early in life, we aim to reprogram immune development to
More news about: Siolta Therapeutics
Nov 17, 2025, 05:07 ET Boricua Author Giannina Braschi Headlines American Studies Association (ASA)
https://theasa.net/phd2025 For more information, contact: [email protected].
More news about: FlowerSong Press
Nov 17, 2025, 05:07 ET La autora boricua Giannina Braschi encabeza la American Studies Association (ASA)
https://theasa.net/phd2025 Para más información, contacte con: [email protected].
More news about: FlowerSong Press
Nov 17, 2025, 02:00 ET Accession Therapeutics doses first patient in Phase 1 clinical trial of TROCEPT-01 (ATTR-01), a novel cancer immunotherapy
tumours where there is significant need for better treatment outcomes". Bent Jakobsen, PhD FMedSci, CEO of Accession Therapeutics, said: "Dosing the first patient in our TROCEPT-01 clinical trial is a pivotal moment for Accession
More news about: Accession Therapeutics
Nov 15, 2025, 11:00 ET BrainXell Showcases Pioneering iPSC Research and Promising In Vivo Data for BXT-110 for Parkinson's Disease at the 2025 Society for Neuroscience Annual Meeting
biotechnology companies pioneering iPSC-based solutions for discovery, translational modeling, and regenerative medicine. Founded by Dr. Su-Chun Zhang, MD, PhD, Founder and Advising CSO, a global leader in stem-cell neuroscience, BrainXell integrates scientific excellence with manufacturing innovation to accelerate
More news about: BrainXell, Inc
Nov 14, 2025, 08:30 ET Newark's La Casa de Don Pedro Opens 'El Barrio Wellness,' Reviving City Landmark for a New Era of Community Health
Wellness and partner with La Casa de Don Pedro in expanding access to locally informed mental health services in Newark," said Balpreet Grewal-Virk, PhD, senior vice president, community health, RWJBarnabas Health. "La Casa de Don Pedro is a trusted neighbor and catalyst for change in the city. Their
More news about: La Casa de Don Pedro